A notable research effort, known as the STEP (Semaglutide GLP-1 Treatment Effect in People with Obesity) trial, revealed that participants taking Semaglutide GLP-1 achieved an average weight reduction of around 15% of their starting body weight within 68 weeks, unlike those taking a placebo
Myocardial scarring is thought to either induce or maintain ventricular arrhythmias in several ways: 1) scarring creates insulating barriers that form alterations in conduction in the fibrotic tissue, resulting in re-entrant wave fronts of excitation
Its a hormonal disorder that can lead to symptoms such as weight gain, acne, hair loss, and infertility
If nothing has changed by week 3, the common next step is 2 mL or a move to daily 1 mL before deciding it does not work for you
10.1111/j.1469-8137.2005.01598.x New Phytol
Furthermore, obesity and T2DM lead to systemic inflammation, increasing pro-inflammatory brain cytokines, which may, in turn, interfere with insulin signaling and neurotransmission [92]